Innovation continues to transform modern care for patients with #MultipleMyeloma (MM). New developments with CD38 antibodies and BCMA immunotherapy have clear implications for oncology nurses, who play a pivotal role in the management of MM as caregivers, educators, patient advocates, and conduits for the coordination and delivery of care.
In collaboration with the HealthTree Foundation for Multiple Myeloma and #ONS2024, this #PeerView Seminar and Nurse Workshop initiative will feature a panel of expert oncology nurses who will use a series of ten case-based learning sessions to provide guidance on modern patient assessment, therapy selection, dosing, and adverse event management when using CD38 antibody platforms, BCMA immunotherapies, and other innovative therapeutics. Register today and don’t miss this opportunity to join the #oncology #nurse experts Beth Faiman PhD, MSN, APN-BC,BMTCN, AOCN, FAAN, FAPO, Donna Catamero, ANP-BC, OCN, CCRC, and Charise Gleason NP, MSN, NP-C, AOCN, to take steps to improve patient care! https://bit.ly/MM24L #MedEd #ONS2024
This activity is supported by educational grants from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, Regeneron Pharmaceuticals, Inc., and Sanofi
Director Sales, East Zone US at Sanofi
1mo💪💪💪